NEW YORK (GenomeWeb) – Metamark today announced that it has signed an agreement to provide its suite of urology diagnostics to 5.2 million Highmark Blue Shield members in Delaware, Pennsylvania, and West Virginia.

Cambridge, Mass.-based Metamark provides a comprehensive suite of diagnostic and prognostic tools for urology, including the Promark prostate cancer panel.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

The London School of Economics' Daniele Fanelli argues at the Proceedings of the National Academy of Sciences that the reproducibility crisis in science isn't as dire as some say.

A team of researchers in Portugal has examined the genomic basis for racing pigeons' athleticism and navigational skills, finding it's likely polygenic.

Wired reports that diagnostic firms continue to seek, post-Theranos, the ability to diagnose diseases from small amounts of blood.

In Science this week: analysis of DNA from ancient North Africans, and more.